Filter
771
Text search:
drug
dosing
Featured
Recommendations
112
New Publications
193
Language
Document type
No document type
411
Guidelines
179
Studies & Reports
92
Manuals
35
Training Material
18
Strategic & Response Plan
14
Fact sheets
14
Situation Updates
3
Resource Platforms
2
App
1
Infographics
1
Online Courses
1
Countries / Regions
India
44
South Africa
33
Kenya
23
Global
23
Tanzania
21
Ethiopia
18
Uganda
14
Zambia
14
Africa
11
Ghana
10
Nepal
10
Namibia
10
Rwanda
9
Sierra Leone
7
Nigeria
7
Zimbabwe
7
Malawi
7
Bangladesh
6
Myanmar / Burma
6
Western and Central Europe
6
Philippines
5
Latin America and the Carribbean
5
Liberia
4
USA
4
Cambodia
4
South Sudan
3
Eswatini/ Swaziland
3
Lesotho
3
Congo, Democratic Republic of
2
Syria
2
Argentina
2
Ukraine
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Burkina Faso
1
Senegal
1
Mali
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Germany
1
Chad
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Brazil
1
Botswana
1
Angola
1
East and Southern Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Oman
1
Authors & Publishers
Publication Years
Category
Countries
253
Clinical Guidelines
146
Women & Child Health
41
Public Health
23
Capacity Building
21
Key Resources
8
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
114
TB
89
AMR
62
NTDs
34
Pharmacy
33
Mental Health
32
Malaria
31
COVID-19
23
NCDs
20
Caregiver
12
Ebola & Marburg
8
Conflict
6
Cholera
5
Refugee
5
Polio
3
Planetary Health
3
Health Financing Toolbox
3
Rapid Response
2
Specific Hazards
2
Disability
1
Zika
1
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE
...
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of
...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Bridging the Gap
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p
...
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
Updated May 2021
